• Prostate Cancer Biotec AG in Liquidation

    ZG
    in liquidation
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-170.3.045.351-4
    Sector: Research and development

    Age of the company

    4 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    100'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Prostate Cancer Biotec AG in Liquidation

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Prostate Cancer Biotec AG in Liquidation

    • Prostate Cancer Biotec AG in Liquidation with its legal headquarters in Zug is in liquidation. Prostate Cancer Biotec AG in Liquidation operates in the sector «Research and development».
    • The management of the company Prostate Cancer Biotec AG in Liquidation, which was founded on the 25.01.2021, consists of one person.
    • All modifications to the commercial register entry can be found under «Notifications». The most recent modification was made on 10.03.2025.
    • The UID registered in the commercial register of ZG is CHE-212.353.127.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten und Technologien. Die Gesellschaft kann Immaterialgüterrechte und Lizenzen jeder Art erwerben, halten und veräussern. Die Gesellschaft kann alle kommerziellen, vertraglichen und finanziellen Geschäfte eingehen, die geeignet sind, den Zweck der Gesellschaft zu fördern, oder die direkt oder indirekt damit in Zusammenhang stehen. Ferner kann sie Zweigniederlassungen im In- und Ausland errichten und sich an anderen Unternehmungen beteiligen oder sich mit diesen zusammenschliessen. Die Gesellschaft kann Grundstücke erwerben, veräussern und verwalten.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Caminada Treuhand AG Zürich
    Zürich 28.01.2021

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Past and translated company names

    • Prostate Cancer Biotec SA en liquidation
    • Prostate Cancer Biotec Ltd in liquidation
    • Prostate Cancer Biotec SA
    • Prostate Cancer Biotec AG
    • Prostate Cancer Biotec Ltd
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Prostate Cancer Biotec AG in Liquidation

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250310/2025 - 10.03.2025
    Categories: Liquidation, Change of company name, Change in management

    Publication number: HR02-1006277433, Commercial Registry Office Zug, (170)

    Prostate Cancer Biotec AG, in Zug, CHE-212.353.127, Aktiengesellschaft (SHAB Nr. 19 vom 28.01.2021, Publ. 1005085823).

    Firma neu:
    Prostate Cancer Biotec AG in Liquidation.

    Uebersetzungen der Firma neu:
    (Prostate Cancer Biotec SA en liquidation) (Prostate Cancer Biotec Ltd in liquidation). Die Gesellschaft ist mit Beschluss der Generalversammlung vom 20.02.2025 aufgelöst.

    Ausgeschiedene Personen und erloschene Unterschriften:
    Blum, Dr. Claude, von Zürich, in Oberrieden, Präsident des Verwaltungsrates, mit Einzelunterschrift;
    Fontana, Adriano, von Capriasca, in Bad Ragaz, Zeichnungsberechtigter, mit Kollektivunterschrift zu zweien.

    Eingetragene Personen neu oder mutierend:
    Hirzel, Adrian, von Zürich, in Zollikon, Liquidator, mit Einzelunterschrift [bisher: Mitglied des Verwaltungsrates, mit Einzelunterschrift].

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm